Leishmaniasis, Visceral: Clinical Trials

5 trials for Leishmaniasis, Visceral, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated, 1 unknown. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Completed 3, Terminated 1, Unknown 1

Follow Leishmaniasis, Visceral: new trials by email Literature Review of Leishmaniasis, Visceral trials Research Report on Leishmaniasis, Visceral

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis
AMBISOME - Visceral Leishmaniasis
Phase 4UnknownBanaras Hindu University13002014-06-012014-01-22
Safety and Effectiveness of Short-course AmBisome in the Treatment of PKDL in Bangladesh
AmBisome - Post-kala-azar Dermal Leishmaniasis
Phase 4CompletedMedecins Sans Frontieres, Netherlands2802014-04-082017-10-17
Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil
Antimoniate of N-methylglucamine, amphotericin B deoxycholate, Liposomal amphotericin B - Visceral Leishmaniasis
Phase 4TerminatedUniversity of Brasilia3782011-02-012017-09-05
Expand Access/Assess Safety and Efficacy of Paromomycin IM Injection for the Treatment of Visceral Leishmaniasis
Paromomycin sulfate - Visceral Leishmaniasis
Phase 4CompletedPATH20002007-10-012014-10-03
Amphotericin B to Treat Visceral Leishmaniasis in Brazilian Children
Meglumine antimoniate, Amphotericin B-deoxycholate - Visceral Leishmaniasis
Phase 4CompletedUniversity of Brasilia1012007-10-012017-09-05

Broader conditions

Euglenozoa Infections (5)  ·  Infections (5)  ·  Leishmaniasis (5)  ·  Parasitic Diseases (5)  ·  Protozoan Infections (5)  ·  Vector Borne Diseases (5)

Interventions

liposomal amphotericin B (3)  ·  Amphotericin B (2)  ·  Meglumine Antimoniate (2)  ·  amphotericin B, deoxycholate drug combination (2)  ·  Paromomycin (1)

Sponsors

University of Brasilia (2)  ·  Banaras Hindu University (1)  ·  Medecins Sans Frontieres, Netherlands (1)  ·  PATH (1)

Countries

Brazil (2)  ·  India (2)

Top investigators

Amrendra K Aditya, MD (1)  ·  Ana LT Rabello, MD PhD (1)  ·  Andrea L de Carvalho, MD (1)  ·  C P Thakur, MD (1)  ·  Carlos HN Costa, MD PhD (1)  ·  Devendra Nath, MD (1)  ·  Dorcas L Costa, MD PhD (1)  ·  Fabiana P Alves, MD PhD (1)  ·  Gustavo AS Romero, MD PhD (1)  ·  Gustavo AS Romero, PhD (1)  ·  Koert Ritmeijer, PhD (1)  ·  Myrlena RM Borges, MsC (1)  ·  P K Sinha, MD (1)  ·  Roque P de Almeida, MD PhD (1)

Results publications

PMID 28327804, PMID 28662034